You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:


Last Updated: August 5, 2020

DrugPatentWatch Database Preview

ETHACRYNIC ACID - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for ethacrynic acid and what is the scope of patent protection?

Ethacrynic acid is the generic ingredient in two branded drugs marketed by Bausch, Agnitio, Alvogen, Amneal Pharms Co, Edenbridge Pharms, Hikma, Lupin Ltd, Par Pharm Inc, Sciegen Pharms Inc, and Upsher Smith Labs, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for ethacrynic acid. Twelve suppliers are listed for this compound.


See drug prices for ETHACRYNIC ACID

Recent Clinical Trials for ETHACRYNIC ACID

Identify potential brand extensions & 505(b)(2) entrants

Neupharma SrlPhase 1
Pari Pharma GmbHPhase 1
Aptuit SrlPhase 1

See all ETHACRYNIC ACID clinical trials

Pharmacology for ETHACRYNIC ACID
Medical Subject Heading (MeSH) Categories for ETHACRYNIC ACID

US Patents and Regulatory Information for ETHACRYNIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch EDECRIN ethacrynic acid TABLET;ORAL 016092-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Edenbridge Pharms ETHACRYNIC ACID ethacrynic acid TABLET;ORAL 205609-001 Jun 30, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Bausch EDECRIN ethacrynic acid TABLET;ORAL 016092-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.